Crossmark

Peripheral vascular responses to acetylcholine as a predictive tool for response to cholinesterase inhibitors in Alzheimer’s disease

Published Online: 2019-05-03

Published Print: 2019-12

Authors

Connelly, Peter J.

Adams, Fiona

Tayar, Ziad I.

Khan, Faisel http://orcid.org/0000-0002-9889-0229
Funding

Funding for this research was provided by:

Anonymous Trust, Dundee (AT1AD)
License Information

Text and Data Mining valid from 2019-05-03
More Information

Article History

Received: 4 April 2018

Accepted: 24 April 2019

First Online: 3 May 2019

Ethics approval and consent to participate

: All participants gave written informed consent to the study, which was approved by the East of Scotland Research Ethics Service (REC reference 11/AL/0259).

: Not applicable.

: PJC acts as Principal Investigator in clinical trials sponsored by Biogen, Axovant, Boehringer Ingelheim, Roche, Eli Lilly and has in the past (not in the past five years) received expenses, honoraria and speaker fees from Eisai, Novartis, Janssen and Lundbeck. FA, ZT and FK have no competing interests to declare.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current